Indeed, numerous studies showed in human laryngeal squamous cell carcinomas and in orthotopic mouse model of HNSCC that combining a Tregs inhibitor-based treatment with radiotherapy and PD-L1 blockade induces a tumor growth delay, a decrease of Treg numbers and an increased survival [39,40]. Here, CD274 is linked to head and neck squamous cell carcinoma.